234 related articles for article (PubMed ID: 34195201)
1. The C-X-C Motif Chemokine Ligand 1 Sustains Breast Cancer Stem Cell Self-Renewal and Promotes Tumor Progression and Immune Escape Programs.
Ciummo SL; D'Antonio L; Sorrentino C; Fieni C; Lanuti P; Stassi G; Todaro M; Di Carlo E
Front Cell Dev Biol; 2021; 9():689286. PubMed ID: 34195201
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-30 feeds breast cancer stem cells via CXCL10 and IL23 autocrine loops and shapes immune contexture and host outcome.
Sorrentino C; Ciummo SL; D'Antonio L; Fieni C; Lanuti P; Turdo A; Todaro M; Di Carlo E
J Immunother Cancer; 2021 Oct; 9(10):. PubMed ID: 34663639
[TBL] [Abstract][Full Text] [Related]
3. BRD4/nuclear PD-L1/RelB circuit is involved in the stemness of breast cancer cells.
Kim SL; Choi HS; Lee DS
Cell Commun Signal; 2023 Nov; 21(1):315. PubMed ID: 37924094
[TBL] [Abstract][Full Text] [Related]
4. Suppression of apoptosis inhibitor c-FLIP selectively eliminates breast cancer stem cell activity in response to the anti-cancer agent, TRAIL.
Piggott L; Omidvar N; Martí Pérez S; French R; Eberl M; Clarkson RW
Breast Cancer Res; 2011 Sep; 13(5):R88. PubMed ID: 21914219
[TBL] [Abstract][Full Text] [Related]
5. Elimination of epithelial-like and mesenchymal-like breast cancer stem cells to inhibit metastasis following nanoparticle-mediated photothermal therapy.
Paholak HJ; Stevers NO; Chen H; Burnett JP; He M; Korkaya H; McDermott SP; Deol Y; Clouthier SG; Luther T; Li Q; Wicha MS; Sun D
Biomaterials; 2016 Oct; 104():145-57. PubMed ID: 27450902
[TBL] [Abstract][Full Text] [Related]
6. Cancer stem cell-derived CHI3L1 activates the MAF/CTLA4 signaling pathway to promote immune escape in triple-negative breast cancer.
Ji S; Yu H; Zhou D; Fan X; Duan Y; Tan Y; Lang M; Shao G
J Transl Med; 2023 Oct; 21(1):721. PubMed ID: 37838657
[TBL] [Abstract][Full Text] [Related]
7. PMN-MDSCs modulated by CCL20 from cancer cells promoted breast cancer cell stemness through CXCL2-CXCR2 pathway.
Zhang R; Dong M; Tu J; Li F; Deng Q; Xu J; He X; Ding J; Xia J; Sheng D; Chang Z; Ma W; Dong H; Zhang Y; Zhang L; Zhang L; Liu S
Signal Transduct Target Ther; 2023 Mar; 8(1):97. PubMed ID: 36859354
[TBL] [Abstract][Full Text] [Related]
8. Chemokine (C-X-C motif) ligand 1/chemokine (C-X-C motif) receptor 2 autocrine loop contributes to cellular proliferation, migration and apoptosis in cervical cancer.
Sun J; Yuan J
Bioengineered; 2022 Mar; 13(3):7579-7591. PubMed ID: 35264061
[TBL] [Abstract][Full Text] [Related]
9. Up-regulation of miR-210 induced by a hypoxic microenvironment promotes breast cancer stem cells metastasis, proliferation, and self-renewal by targeting E-cadherin.
Tang T; Yang Z; Zhu Q; Wu Y; Sun K; Alahdal M; Zhang Y; Xing Y; Shen Y; Xia T; Xi T; Pan Y; Jin L
FASEB J; 2018 Sep; ():fj201801013R. PubMed ID: 30188754
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-8, but not the Related Chemokine CXCL1, Sustains an Autocrine Circuit Necessary for the Properties and Functions of Thyroid Cancer Stem Cells.
Liotti F; Collina F; Pone E; La Sala L; Franco R; Prevete N; Melillo RM
Stem Cells; 2017 Jan; 35(1):135-146. PubMed ID: 27577959
[TBL] [Abstract][Full Text] [Related]
11. XIAOPI Formula Inhibits Breast Cancer Stem Cells
Wang S; Liu X; Huang R; Zheng Y; Wang N; Yang B; Situ H; Lin Y; Wang Z
Front Pharmacol; 2019; 10():1371. PubMed ID: 31803057
[TBL] [Abstract][Full Text] [Related]
12. CXCL1 derived from tumor-associated macrophages promotes breast cancer metastasis via activating NF-κB/SOX4 signaling.
Wang N; Liu W; Zheng Y; Wang S; Yang B; Li M; Song J; Zhang F; Zhang X; Wang Q; Wang Z
Cell Death Dis; 2018 Aug; 9(9):880. PubMed ID: 30158589
[TBL] [Abstract][Full Text] [Related]
13. Receptor-Interacting Protein Kinase 3 Deficiency Recruits Myeloid-Derived Suppressor Cells to Hepatocellular Carcinoma Through the Chemokine (C-X-C Motif) Ligand 1-Chemokine (C-X-C Motif) Receptor 2 Axis.
Li YM; Liu ZY; Wang JC; Yu JM; Li ZC; Yang HJ; Tang J; Chen ZN
Hepatology; 2019 Nov; 70(5):1564-1581. PubMed ID: 31021443
[TBL] [Abstract][Full Text] [Related]
14. Exploring the interplay between triple-negative breast cancer stem cells and tumor microenvironment for effective therapeutic strategies.
Zou Z; Luo T; Wang X; Wang B; Li Q
J Cell Physiol; 2024 May; ():. PubMed ID: 38807378
[TBL] [Abstract][Full Text] [Related]
15. CXCL1-LCN2 paracrine axis promotes progression of prostate cancer via the Src activation and epithelial-mesenchymal transition.
Lu Y; Dong B; Xu F; Xu Y; Pan J; Song J; Zhang J; Huang Y; Xue W
Cell Commun Signal; 2019 Sep; 17(1):118. PubMed ID: 31500632
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathologic significance of the CXCL1-CXCR2 axis in the tumor microenvironment of gastric carcinoma.
Kasashima H; Yashiro M; Nakamae H; Masuda G; Kinoshita H; Morisaki T; Fukuoka T; Hasegawa T; Nakane T; Hino M; Hirakawa K; Ohira M
PLoS One; 2017; 12(6):e0178635. PubMed ID: 28575019
[TBL] [Abstract][Full Text] [Related]
17. Homeobox B5 promotes metastasis and poor prognosis in Hepatocellular Carcinoma, via FGFR4 and CXCL1 upregulation.
He Q; Huang W; Liu D; Zhang T; Wang Y; Ji X; Xie M; Sun M; Tian D; Liu M; Xia L
Theranostics; 2021; 11(12):5759-5777. PubMed ID: 33897880
[No Abstract] [Full Text] [Related]
18. The Clinicopathological Significance of the CXCR2 Ligands, CXCL1, CXCL2, CXCL3, CXCL5, CXCL6, CXCL7, and CXCL8 in Gastric Cancer.
Yamamoto Y; Kuroda K; Sera T; Sugimoto A; Kushiyama S; Nishimura S; Togano S; Okuno T; Yoshii M; Tamura T; Toyokawa T; Tanaka H; Muguruma K; Ohira M; Yashiro M
Anticancer Res; 2019 Dec; 39(12):6645-6652. PubMed ID: 31810929
[TBL] [Abstract][Full Text] [Related]
19. Tumor Necrosis Factor-α (TNFα) Stimulate Triple-Negative Breast Cancer Stem Cells to Promote Intratumoral Invasion and Neovasculogenesis in the Liver of a Xenograft Model.
Narasimhan H; Ferraro F; Bleilevens A; Weiskirchen R; Stickeler E; Maurer J
Biology (Basel); 2022 Oct; 11(10):. PubMed ID: 36290384
[TBL] [Abstract][Full Text] [Related]
20. Baohuoside i suppresses breast cancer metastasis by downregulating the tumor-associated macrophages/C-X-C motif chemokine ligand 1 pathway.
Wang S; Wang N; Huang X; Yang B; Zheng Y; Zhang J; Wang X; Lin Y; Wang Z
Phytomedicine; 2020 Nov; 78():153331. PubMed ID: 32911383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]